Bio-View Ltd (TLV:BIOV)
16.60
-0.60 (-3.49%)
Oct 5, 2025, 3:49 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 22.25 million as of October 7, 2025. Its market cap has decreased by -32.71% in one year.
Market Cap
22.25M
Enterprise Value
16.26M
Revenue
17.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.60
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 22.25M, a decrease of -62.80%. That is a compound annual growth rate of -4.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 5, 2025 | 22.25M | -37.67% |
Dec 31, 2024 | 35.69M | -21.62% |
Dec 31, 2023 | 45.53M | -10.12% |
Dec 29, 2022 | 50.66M | 13.09% |
Dec 30, 2021 | 44.79M | -20.07% |
Dec 31, 2020 | 56.04M | 29.86% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 75.93B |
Danel (Adir Yeoshua) | 3.00B |
Kamada | 1.31B |
Bait Bakfar | 974.87M |
BrainsWay | 961.20M |
SofWave Medical | 943.38M |
Ilex Medical | 714.47M |
Novolog (Pharm-Up 1966) | 661.07M |